Merck's HIV treatment meets main goal of two late-stage studies
(Reuters) - Merck said on Thursday its experimental drug combination to treat some adults with HIV-1 infection met the main goal of two late-stage studies.
(Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)
Terms and Privacy Policy